312 related articles for article (PubMed ID: 25815178)
1. Strategies for preserving residual renal function in peritoneal dialysis patients.
Nongnuch A; Assanatham M; Panorchan K; Davenport A
Clin Kidney J; 2015 Apr; 8(2):202-11. PubMed ID: 25815178
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study.
Shen JI; Saxena AB; Vangala S; Dhaliwal SK; Winkelmayer WC
BMC Nephrol; 2017 Jun; 18(1):196. PubMed ID: 28623899
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Residual Renal Function Decline in Peritoneal Dialysis Patients: The
Htay H; Cho Y; Pascoe EM; Darssan D; Hawley C; Johnson DW;
Perit Dial Int; 2017; 37(3):283-289. PubMed ID: 27935537
[TBL] [Abstract][Full Text] [Related]
4. Incremental haemodialysis.
Wong J; Vilar E; Davenport A; Farrington K
Nephrol Dial Transplant; 2015 Oct; 30(10):1639-48. PubMed ID: 26038351
[TBL] [Abstract][Full Text] [Related]
5. [Factors related to loss of residual renal function in peritoneal dialysis].
Coronel F; Pérez Flores I
Nefrologia; 2008; 28 Suppl 6():39-44. PubMed ID: 18957011
[TBL] [Abstract][Full Text] [Related]
6. Rationale and Strategies for Preserving Residual Kidney Function in Dialysis Patients.
Li T; Wilcox CS; Lipkowitz MS; Gordon-Cappitelli J; Dragoi S
Am J Nephrol; 2019; 50(6):411-421. PubMed ID: 31630148
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on cardiovascular events and residual renal function in dialysis patients: a meta-analysis of randomised controlled trials.
Liu Y; Ma X; Zheng J; Jia J; Yan T
BMC Nephrol; 2017 Jun; 18(1):206. PubMed ID: 28666408
[TBL] [Abstract][Full Text] [Related]
8. Residual renal function in children treated with chronic peritoneal dialysis.
Roszkowska-Blaim M; Skrzypczyk P
ScientificWorldJournal; 2013 Nov; 2013():154537. PubMed ID: 24376376
[TBL] [Abstract][Full Text] [Related]
9. Prescribing high-quality peritoneal dialysis: The role of preserving residual kidney function.
Chen CH; Perl J; Teitelbaum I
Perit Dial Int; 2020 May; 40(3):274-281. PubMed ID: 32063188
[TBL] [Abstract][Full Text] [Related]
10. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study.
Li PK; Chow KM; Wong TY; Leung CB; Szeto CC
Ann Intern Med; 2003 Jul; 139(2):105-12. PubMed ID: 12859160
[TBL] [Abstract][Full Text] [Related]
11. Extracellular volume expansion and the preservation of residual renal function in Korean peritoneal dialysis patients: a long-term follow up study.
Rhee H; Baek MJ; Chung HC; Park JM; Jung WJ; Park SM; Lee JW; Shin MJ; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Clin Exp Nephrol; 2016 Oct; 20(5):778-786. PubMed ID: 26611535
[TBL] [Abstract][Full Text] [Related]
12. [Maintaining residual renal function in patients on dialysis].
Ryckelynck JP; Goffin É; Verger C;
Nephrol Ther; 2013 Nov; 9(6):403-7. PubMed ID: 23768756
[TBL] [Abstract][Full Text] [Related]
13. On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease.
Tanriover C; Ucku D; Basile C; Tuttle KR; Kanbay M
J Nephrol; 2022 Dec; 35(9):2191-2204. PubMed ID: 35819749
[TBL] [Abstract][Full Text] [Related]
14. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
Huang WH; Hung CC; Yang CW; Huang JY
Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
[TBL] [Abstract][Full Text] [Related]
15. Advances in Understanding and Management of Residual Renal Function in Patients with Chronic Kidney Disease.
Liu X; Dai C
Kidney Dis (Basel); 2017 Jan; 2(4):187-196. PubMed ID: 28232935
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.
Chen YR; Yang Y; Wang SC; Chiu PF; Chou WY; Lin CY; Chang JM; Chen TW; Ferng SH; Lin CL
Nephrol Dial Transplant; 2013 Mar; 28(3):671-82. PubMed ID: 23223224
[TBL] [Abstract][Full Text] [Related]
17. Does Routine Bioimpedance-Guided Fluid Management Provide Additional Benefit to Non-Anuric Peritoneal Dialysis Patients? Results from COMPASS Clinical Trial.
Oh KH; Baek SH; Joo KW; Kim DK; Kim YS; Kim S; Oh YK; Han BG; Chang JH; Chung W; Na KY;
Perit Dial Int; 2018; 38(2):131-138. PubMed ID: 29386302
[TBL] [Abstract][Full Text] [Related]
18. Definition and risk factors of rapidly declining residual renal function in peritoneal dialysis: an observational study.
Herget-Rosenthal S; von Ostrowski M; Kribben A
Kidney Blood Press Res; 2012; 35(4):233-41. PubMed ID: 22223267
[TBL] [Abstract][Full Text] [Related]
19. The importance of residual renal function in dialysis patients.
Wang AY; Lai KN
Kidney Int; 2006 May; 69(10):1726-32. PubMed ID: 16612329
[TBL] [Abstract][Full Text] [Related]
20. Baseline and Time-Averaged Values Predicting Residual Renal Function Decline Rate in Japanese Peritoneal Dialysis Patients.
Uchiyama K; Yanai A; Maeda K; Ono K; Honda K; Tsujimoto R; Kamijo Y; Yanagi M; Ishibashi Y
Ther Apher Dial; 2017 Dec; 21(6):599-605. PubMed ID: 29047213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
